vTv Therapeutics Income Statement (2014-2026) | VTVT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Shares Outstanding (Entity) (Quarter)	0.74M	0.74M	0.80M	0.77M	0.76M	0.85M	0.87M	0.89M	0.90M	0.90M	0.90M	0.90M	1.31M	1.34M	1.35M	1.63M	1.67M	6.31M	6.31M	0.62M
Revenue & cost
Revenue (Quarter)	0.01M	3.00M	0.01M	2.00M	0.01M		0.01M					1.00M			0.02M					36.84M
Operating items
Research & Development (Quarter)	2.44M	2.38M	5.40M	3.13M	2.21M	3.06M	3.96M	3.94M	4.69M	2.82M	2.14M	2.65M	3.44M	3.22M	2.23M	2.83M	4.10M	7.02M	3.91M	8.98M
Selling, General & Administrative (Quarter)	2.24M	2.22M	5.72M	5.35M	1.83M	2.63M	2.39M	3.48M	3.31M	2.54M	2.57M	3.98M	3.72M	3.28M	2.67M	3.67M	3.62M	3.68M	3.98M	4.60M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	4.68M	4.60M	11.12M	8.48M	4.04M	5.69M	6.35M	7.43M	8.00M	5.37M	4.71M	6.63M	7.16M	6.51M	4.91M	6.50M	7.72M	10.70M	7.88M	13.58M
Operating Income (Quarter)	-4.67M	-1.60M	-11.11M	-6.48M	-4.03M	-5.69M	-6.34M	-7.43M	-8.00M	-5.37M	-4.71M	-5.63M	-7.16M	-6.51M	-4.89M	-6.50M	-7.72M	-10.70M	-7.88M	23.26M
EBIT (Quarter)	-4.67M	-1.60M	-11.11M	-6.48M	-4.03M	-5.69M	-6.34M	-7.43M	-8.00M	-5.37M	-4.71M	-5.63M	-7.16M	-6.51M	-4.89M	-6.50M	-7.72M	-10.70M	-7.88M	23.26M
Non-operating items
Interest & Investment Income (Quarter)					0.05M	0.15M	0.15M	0.10M	0.15M	0.13M	0.09M	0.08M	0.55M	0.50M	0.43M	0.33M	0.28M	0.40M	0.86M	0.84M
Other Non Operating Income (Quarter)	2.90M	-1.08M	0.63M	-3.23M	0.05M	-0.32M	-3.84M	-0.24M	0.30M	-3.64M	0.17M		0.07M	0.08M	0.00M	-0.02M	0.05M	-0.03M	-0.07M	0.02M
Non Operating Income (Quarter)
Net income details
EBT (Quarter)	-0.84M	-1.36M	-9.48M	-9.22M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-5.92M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M	-7.14M	24.13M
Tax Provisions (Quarter)		0.10M		0.20M								0.10M
Profit After Tax (Quarter)	-0.84M	-1.09M	-9.48M	-9.42M	-3.15M	-4.26M	-4.75M	-4.50M	-5.62M	-8.54M	1.27M	-4.87M	-5.18M	-5.84M	-7.88M	-6.22M	-7.38M	-10.35M	-7.14M	24.13M
Income from Non-Controlling Interests (Quarter)	-0.23M	-0.38M	-2.43M	-2.42M	-0.94M	-1.21M	-1.34M	-1.27M	-1.59M	-1.89M	-0.96M	-1.15M	-1.23M	-1.06M	-0.80M	-1.12M	-1.33M	-1.65M
Income from Continuing Operations (Quarter)	-0.84M	-1.47M	-9.48M	-9.42M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-6.02M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M	-7.14M	24.13M
Consolidated Net Income (Quarter)	-0.84M	-1.47M	-9.48M	-9.42M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-6.02M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M	-7.14M	24.13M
Income towards Parent Company (Quarter)	-0.84M	-1.47M	-9.48M	-9.42M	-4.09M	-5.47M	-6.09M	-5.77M	-7.21M	-8.54M	-4.44M	-6.02M	-6.41M	-5.84M	-4.44M	-6.22M	-7.38M	-10.35M	-7.14M	24.13M
Net Income towards Common Stockholders (Quarter)	-0.61M	-1.09M	-7.05M	-7.01M	-3.15M	-4.26M	-4.75M	-4.50M	-5.62M	-6.65M	-3.48M	-4.87M	-5.18M	-4.78M	-3.63M	-5.09M	-6.05M	-8.70M	-7.14M	24.13M
Additional items
EPS (Basic) (Quarter)	-0.82	-1.47	-8.77	-9.09	-4.13	-5.01	-5.48	-5.08	-6.27	-7.42	-3.85	-5.40	-3.96	-3.56	-2.68	-3.12	-3.63	-1.38	-1.13	38.78
Shares Outstanding (Quarter)	0.74M	0.74M	0.80M	0.77M	0.76M	0.85M	0.87M	0.89M	0.90M	0.90M	0.90M	0.90M	1.31M	1.34M	1.35M	1.63M	1.67M	6.31M	6.31M	0.62M
EBITDA (Quarter)	-4.67M	-1.60M	-11.11M	-6.48M	-4.03M	-5.69M	-6.34M	-7.43M	-8.00M	-5.37M	-4.71M	-5.63M	-7.16M	-6.51M	-4.89M	-6.50M	-7.72M	-10.70M	-7.88M	23.26M
Interest Expenses (Quarter)	0.95M	0.89M	0.01M	0.76M	0.70M	0.63M	0.01M		0.47M	0.42M	0.01M	0.32M	0.27M	0.23M	0.00M	0.13M		0.01M	0.00M	20.73M
Tax Rate (Quarter)		-7.33		-2.17								-1.69

Research Tools

Developers

vTv Therapeutics Income Statement (2014-2026) | VTVT

Research Tools

Developers

vTv Therapeutics Income Statement (2014-2026) | VTVT

Create an account

Sign In

Reset Password